Brief: Grifols Gets EMA Approval For Manufacture And Selling Of Egyptian Plasma
16/12/2025 07:44
Dec 16 (Reuters) - Grifols SA GRLS.MC: RECEIVES EMA (EUROPEAN MEDICINES AGENCY) CERTIFICATION FOR EGYPTIAN PLASMA GEPD (GRIFOLS EGYPT FOR PLASMA DERIVATIVES) AUTHORIZED TO MARKET PLASMA PRODUCTS IN EUROPE Source text Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 567 69 66 00;))
Recent news on Grifols SA
See all newsSpanish stocks - Factors to watch on June 24
Brief: Grifols Approves Reduction Of Up To 10% Of Its Share Capital
Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
Brief: Grifols' Egypt Unit Adds €180 Mln Of Additional Investment In Project
Spanish stocks - Factors to watch on June 12